@article{ref1,
title="Steroid-induced osteoporosis. Are your asthmatic patients at risk?",
journal="Postgraduate medicine",
year="1999",
author="Niewoehner, C. B. and Niewoehner, D. E.",
volume="105",
number="3",
pages="79-83, 87",
abstract="Asthmatic patients who rely on long-term, high-dose corticosteroid therapy are at increased risk for osteoporosis. The use of low-dose inhaled corticosteroids may be safe enough not to require special assessment of bone loss or preventive measures. However, evidence is lacking on the risks of long-term use of higher doses. Regardless of dose, all patients given long-term systemic corticosteroids should be carefully examined and, if necessary, treated for bone loss.<p /><p>Language: en</p>",
language="en",
issn="0032-5481",
doi="",
url="http://dx.doi.org/"
}